Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys

Abstract

Summary Background Worldwide implementation of risk-based cardiovascular disease (CVD) prevention requires risk prediction tools that are contemporarily recalibrated for the target country and can be used where laboratory measurements are unavailable. We present two cardiovascular risk scores, with and without laboratory-based measurements, and the corresponding risk charts for 182 countries to predict 10-year risk of fatal and non-fatal CVD in adults aged 40–74 years. Methods Based on our previous laboratory-based prediction model (Globorisk), we used data from eight prospective studies to estimate coefficients of the risk equations using proportional hazard regressions. The laboratory-based risk score included age, sex, smoking, blood pressure, diabetes, and total cholesterol; in the non-laboratory (office-based) risk score, we replaced diabetes and total cholesterol with BMI. We recalibrated risk scores for each sex and age group in each country using country-specific mean risk factor levels and CVD rates. We used recalibrated risk scores and data from national surveys (using data from adults aged 40–64 years) to estimate the proportion of the population at different levels of CVD risk for ten countries from different world regions as examples of the information the risk scores provide; we applied a risk threshold for high risk of at least 10% for high-income countries (HICs) and at least 20% for low-income and middle-income countries (LMICs) on the basis of national and international guidelines for CVD prevention. We estimated the proportion of men and women who were similarly categorised as high risk or low risk by the two risk scores. Findings Predicted risks for the same risk factor profile were generally lower in HICs than in LMICs, with the highest risks in countries in central and southeast Asia and eastern Europe, including China and Russia. In HICs, the proportion of people aged 40–64 years at high risk of CVD ranged from 1% for South Korean women to 42% for Czech men (using a ≥10% risk threshold), and in low-income countries ranged from 2% in Uganda (men and women) to 13% in Iranian men (using a ≥20% risk threshold). More than 80% of adults were similarly classified as low or high risk by the laboratory-based and office-based risk scores. However, the office-based model substantially underestimated the risk among patients with diabetes. Interpretation Our risk charts provide risk assessment tools that are recalibrated for each country and make the estimation of CVD risk possible without using laboratory-based measurements.

Aging and Cardiometabolic Risk in European HEMS Pilots: An Assessment of Occupational Old‐Age Limits as a Regulatory Risk Management Strategy

“…Furthermore, mortality differences between countries may not translate to corresponding differences in disease incidence, as case fatality rates may differ. A recently published cardiovascular risk score estimating fatal and nonfatal event risk calibrated to current baseline event rates in different countries suggests that 10‐year event incidence in nondiabetic men aged 40–65 may actually be fairly similar in the four countries represented in our sample …”

Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies

“…It may seem bold to seek one risk score for Latin America as a region, but still worth trying because it could bring great benefits in population screening and disease prevention. With relevant methods, as shown in cardiovascular medicine , along with support from stakeholders and professional bodies, one or a series of country‐specific risk scores could be acceptable and strongly recommended throughout Latin America.…”

Computational models and neural nets: Fantastic models—Where to find them and how to identify them

“…The desire to increase convenience has now led to the wish to simplify the process further by abolishing the most logistically difficult (and expensive) aspect which comprises the cholesterol blood tests. In fact, the Framingham risk engine can be easily reformatted by substituting body mass index for lipids but surprisingly this has not achieved great popularity for initial risk stratification despite its simplicity …”

“…The top features in all machine learning models include some conventional CVD risk factors such as age, blood pressure (BP) and total cholesterol, as well as several new features not included in standard CVD risk calculators such as body mass index (BMI), creatinine, glucose . However, all of these have been previously identified in the Framingham study or have been used other CVD scoring systems (eg QRISK) . Among drug therapies use of anti‐platelet agents was also predictive.…”